NovaBay Pharmaceuticals to Hold 2021 Fourth Quarter and Full Year Conference Call on March 29

Rhea-AI Summary

NovaBay Pharmaceuticals (NYSE American: NBY) will report its financial results for the fiscal year ending December 31, 2021, on March 29, 2022, after market close. An investment community conference call will follow at 4:30 p.m. ET. Participants can pre-register for the call, which will also be available via live webcast. NovaBay, known for Avenova, the leading antimicrobial lid and lash spray, acquired DERMAdoctor in November 2021, enhancing its product offerings in skincare.

Positive

• NovaBay will report financial results on March 29, 2022.
• The acquisition of DERMAdoctor expands product offerings in skincare.

Negative

• None.

EMERYVILLE, Calif.--(BUSINESS WIRE)-- NovaBay^® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2021 after market close on Tuesday, March 29, 2022 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.

Date/Time:				Tuesday, March 29, 4:30 p.m. ET / 1:30 p.m. PT
Pre-Registration:				Participants can pre-register for the conference call here:
				Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.
Dial In:				Those who choose not to pre-register can access the live conference call by dialing the following and requesting the NovaBay Pharmaceuticals call:
				866-777-2509 from within the U.S.
				412-317-5413 from outside the U.S.

The live webcast of the conference call also will be available at http://novabay.com/investors/events. A replay of the call will be available beginning two hours after its completion through April 19, 2022 by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 1992038. The webcast will also be archived at http://novabay.com/investors/events.

About NovaBay Pharmaceuticals, Inc:
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells scientifically created and clinically proven consumer products for the eyecare and skincare markets. Avenova^® is the most prescribed antimicrobial lid and lash spray in the eyecare market. In November 2021, NovaBay acquired DERMAdoctor, LLC, a company offering more than 30 dermatologist-developed skincare products sold through traditional domestic retailers, digital beauty channels and international distributors.

Socialize and Stay Informed on NovaBay’s Progress
Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Visit NovaBay’s Website

Avenova Purchasing Information
For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com
Avenova.com

DERMAdoctor Purchasing Information
For DERMAdoctor purchasing information:
Please call 877-337-6237 or email service@dermadoctor.com
DERMAdoctor.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20220317005008/en/

NovaBay Contact

Justin Hall

Chief Executive Officer and General Counsel

510-899-8800

jhall@novabay.com

Investor Contact

LHA Investor Relations

Jody Cain

310-691-7100

jcain@lhai.com

Source: NovaBay® Pharmaceuticals, Inc.

FAQ

When will NovaBay Pharmaceuticals report its financial results?

NovaBay Pharmaceuticals will report its financial results on March 29, 2022.

What time is the NovaBay Pharmaceuticals conference call?

The conference call will begin at 4:30 p.m. ET on March 29, 2022.

How can I access the NovaBay Pharmaceuticals conference call?

Participants can pre-register or dial in using provided numbers. A live webcast will also be available.

What acquisition did NovaBay Pharmaceuticals make recently?

In November 2021, NovaBay acquired DERMAdoctor, enhancing its skincare product portfolio.

What is NovaBay Pharmaceuticals known for?

NovaBay is known for Avenova, the most prescribed antimicrobial lid and lash spray in the eyecare market.